ZLTQ 27.49 Zeltiq Aesthetics Inc $ZLTQ Hit a 52 week high of 27.99 Closing the day 11/07/14 at 27.49 -0.25 -0.90% With a day low of 26.53 and a total volume of 687,730.
ZLTQ Recent Posts: http://investorshangout.com/Zeltiq-Aesthetics...LTQ-55968/
ZLTQ Zeltiq Aesthetics Inc Recent Headline News
Technical Coverage on Health Care Equipment Stocks - Boston Scientific, Zeltiq Aesthetics, Globus Medical, Volcano, and Stryker
PR Newswire - Thu Nov 06, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ), Globus Medical Inc. (NYSE: GMED), Volcano Corporation (NASDAQ: VOLC), and Stryker Corporation (NYSE: SYK). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Wednesday, November 5, 2014, the NASDAQ Composite ended at 4,620.72, down 0.06%, the Dow Jones Industrial Average advanced 0.58%, to finish the day at 17,484.53, and the S&P 500 closed at 2,023.57, up 0.57%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.22, down 0.19%, while the index has advanced 10.98% in the previous three months. Register for your complimentary reports on these five stocks at:
BSX: 13.24 (-0.12), ZLTQ: 27.49 (-0.25), GMED: 21.48 (-0.58), VOLC: 9.99 (+0.07), SYK: 87.47 (-1.08)
Consumer Names Show Big Growth And New Patterns
at Investor's Business Daily - Wed Nov 05, 4:42PM CST
Stocks from the consumer sector are making their presence felt in today's Spotlight. Some of these companies show outstanding current earnings growth, but digging a little deeper reveals some flaws as well. Zeltiq Aesthetics (ZLTQ) rose briefly after...
JACK: 71.83 (-1.17), ZLTQ: 27.49 (-0.25), RJET: 12.60 (-0.22), CMG: 649.03 (+1.91), FRGI: 55.59 (+0.11)
Zeltiq Aesthetics (ZLTQ) Upgraded From Sell to Hold
at The Street - Mon Nov 03, 9:04AM CST
Zeltiq Aesthetics (ZLTQ) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C-.
ZLTQ: 27.49 (-0.25)
Insider Trading Alert - TYL, SWHC And ZLTQ Traded By Insiders
at The Street - Fri Oct 31, 9:15AM CDT
Stocks with insider trader activity include TYL, SWHC and ZLTQ
ZLTQ: 27.49 (-0.25), TYL: 110.25 (-0.30), SWHC: 9.99 (-0.07)
Owens & Minor Earnings Lag on High Costs, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:04PM CDT
Owens & Minor Inc. (OMI), reported mixed third-quarter 2014 results.
ZLTQ: 27.49 (-0.25), GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21), OMI: 33.95 (-0.27)
Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 48.31 (+0.03), ZLTQ: 27.49 (-0.25), EA: 40.94 (+0.14), AMED: 24.79 (-0.38)
5 Stocks Spiking on Unusual Volume
at The Street - Thu Oct 30, 6:00AM CDT
Keep these stocks rising on unusual volume on your trading radar.
ZLTQ: 27.49 (-0.25), GPRE: 35.03 (+0.77), WMB: 55.38 (+0.67), OMG: 26.70 (+0.06), IPGP: 72.83 (-0.74)
Medtronic Initiates Clinical Study on Latest Heart Valve - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 5:10PM CDT
Medtronic's (MDT) structural heart business expanded in the upper teens owing to exceptional performance delivered by its transcatheter valves.
ZLTQ: 27.49 (-0.25), MDT: 68.10 (-0.64), GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21)
Stock Futures Mixed, Improving; Facebook, Orbital Sciences Dive
at Investor's Business Daily - Wed Oct 29, 8:02AM CDT
Stock futures shifted from losses to mixed trade on the approach to Wednesday's open. Dow futures improved from a narrow decline to trade 16.3 points above fair market value. S&P 500 futures narrowed their losses to a fraction. Nasdaq 100 futures...
ZLTQ: 27.49 (-0.25), ORB: 24.24 (+0.01), FB: 75.60 (+0.34)
Zeltiq beats Street 3Q forecasts
Automated Insights - Tue Oct 28, 6:52PM CDT
PLEASANTON, Calif. (AP) _ Zeltiq Aesthetics Inc. (ZLTQ) on Tuesday reported third-quarter net income of $4.8 million.
ZLTQ: 27.49 (-0.25)
ZELTIQ AESTHETICS
at Investor's Business Daily - Tue Oct 28, 5:43PM CDT
ZELTIQ AESTHETICS (ZLTQ), maker of the CoolSculpting fat-freezing tech, earned 12 cents a share vs. a year-earlier 8-cent loss and views for another 8-cent loss. Revenue surged 55% to $46 mil, topping. Zeltiq raised its full-year revenue and adjusted...
ZLTQ: 27.49 (-0.25)
Zeltiq Aesthetics Earnings: Shaping Up for Another Beat
Rick Munarriz, The Motley Fool - Motley Fool - Tue Oct 28, 4:38PM CDT
Source: Zetliq Aesthetics. Freezing away stubborn fat cells continues to pay off for Zeltiq Aesthetics . The company behind the CoolSculpting platform that's gaining traction in reshaping love handles, abdomens, and thighs posted another...
ZLTQ: 27.49 (-0.25)
ZELTIQ Announces Third Quarter 2014 Financial Results
Marketwired - Tue Oct 28, 3:06PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ)
ZLTQ: 27.49 (-0.25)
Baxter International Gets FDA Nod for Hemophilia A Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 5:45PM CDT
Baxter International Inc.'s (BAX) OBIZUR, cleared for the treatment of bleeding episodes in adults with acquired hemophilia A (AHA), will be commercially available in the U.S. in the coming months.
ZLTQ: 27.49 (-0.25), GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21), BAX: 70.61 (-0.99)
3 Things to Watch When Zeltiq Aesthetics Reports Earnings
Rick Munarriz, The Motley Fool - Motley Fool - Mon Oct 27, 12:24PM CDT
Source: Zetliq Aesthetics. Slimming down remains a challenge for a lot of people, and that's been an opportunity for Zeltiq Aesthetics . The company behind the CoolSculpting platform has been growing quickly as cosmetic surgeons, dietitians,...
ZLTQ: 27.49 (-0.25)
ResMed Posts In-Line Earnings on Revenue Beat in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:50AM CDT
Following the earnings release, ResMed's (RMD) share price rose 9.1% to close at $52.02 on Friday.
ZLTQ: 27.49 (-0.25), GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21), RMD: 51.14 (-0.43)
Strength Seen in ResMed (RMD): Stock Gains 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:46AM CDT
ResMed (RMD) was a big mover last session, with shares rising just over 9% on the day.
ICUI: 71.16 (-0.89), ZLTQ: 27.49 (-0.25), ABAX: 51.63 (-2.21), RMD: 51.14 (-0.43)
Can Fat-Freezer Zeltiq Aesthetics Heat Up Profits?
at Investor's Business Daily - Fri Oct 24, 4:50PM CDT
After some flabby years, things are shaping up for fat-busting technology developer Zeltiq Aesthetics. Zeltiq (ZLTQ) offers people a way to get rid of unwanted fat with its nonsurgical CoolSculpting procedure, which selectively reduces bulges in...
ISRG: 500.02 (-8.63), ELOS: 9.90 (+0.11), VRX: 126.11 (-2.66), ZLTQ: 27.49 (-0.25), VAR: 84.64 (-0.53), CFN: 57.28 (-0.16), STNR: 42.38 (+0.51)
Strength Seen in Cardica (CRDC): Stock Adds 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:25AM CDT
Cardica (CRDC) was a big mover last session, with shares rising over 6% on the day.
ICUI: 71.16 (-0.89), ZLTQ: 27.49 (-0.25), ABAX: 51.63 (-2.21), CRDC: 0.96 (+0.01)
Weakness Seen in Trinity Biotech (TRIB): Stock Tumbles 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 7:44AM CDT
Shares of Trinity Biotech fell nearly 8% last session and witnessed flat revision in current year estimates in the past few weeks suggest a close watch of the firm in the near future.
ZLTQ: 27.49 (-0.25), PAHC: 28.34 (+1.48), GWPH: 73.97 (-0.41), TRIB: 17.43 (-0.42)
ZLTQ Recent Posts: http://investorshangout.com/Zeltiq-Aesthetics...LTQ-55968/
ZLTQ Zeltiq Aesthetics Inc Recent Headline News
Technical Coverage on Health Care Equipment Stocks - Boston Scientific, Zeltiq Aesthetics, Globus Medical, Volcano, and Stryker
PR Newswire - Thu Nov 06, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ), Globus Medical Inc. (NYSE: GMED), Volcano Corporation (NASDAQ: VOLC), and Stryker Corporation (NYSE: SYK). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Wednesday, November 5, 2014, the NASDAQ Composite ended at 4,620.72, down 0.06%, the Dow Jones Industrial Average advanced 0.58%, to finish the day at 17,484.53, and the S&P 500 closed at 2,023.57, up 0.57%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.22, down 0.19%, while the index has advanced 10.98% in the previous three months. Register for your complimentary reports on these five stocks at:
BSX: 13.24 (-0.12), ZLTQ: 27.49 (-0.25), GMED: 21.48 (-0.58), VOLC: 9.99 (+0.07), SYK: 87.47 (-1.08)
Consumer Names Show Big Growth And New Patterns
at Investor's Business Daily - Wed Nov 05, 4:42PM CST
Stocks from the consumer sector are making their presence felt in today's Spotlight. Some of these companies show outstanding current earnings growth, but digging a little deeper reveals some flaws as well. Zeltiq Aesthetics (ZLTQ) rose briefly after...
JACK: 71.83 (-1.17), ZLTQ: 27.49 (-0.25), RJET: 12.60 (-0.22), CMG: 649.03 (+1.91), FRGI: 55.59 (+0.11)
Zeltiq Aesthetics (ZLTQ) Upgraded From Sell to Hold
at The Street - Mon Nov 03, 9:04AM CST
Zeltiq Aesthetics (ZLTQ) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C-.
ZLTQ: 27.49 (-0.25)
Insider Trading Alert - TYL, SWHC And ZLTQ Traded By Insiders
at The Street - Fri Oct 31, 9:15AM CDT
Stocks with insider trader activity include TYL, SWHC and ZLTQ
ZLTQ: 27.49 (-0.25), TYL: 110.25 (-0.30), SWHC: 9.99 (-0.07)
Owens & Minor Earnings Lag on High Costs, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:04PM CDT
Owens & Minor Inc. (OMI), reported mixed third-quarter 2014 results.
ZLTQ: 27.49 (-0.25), GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21), OMI: 33.95 (-0.27)
Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 48.31 (+0.03), ZLTQ: 27.49 (-0.25), EA: 40.94 (+0.14), AMED: 24.79 (-0.38)
5 Stocks Spiking on Unusual Volume
at The Street - Thu Oct 30, 6:00AM CDT
Keep these stocks rising on unusual volume on your trading radar.
ZLTQ: 27.49 (-0.25), GPRE: 35.03 (+0.77), WMB: 55.38 (+0.67), OMG: 26.70 (+0.06), IPGP: 72.83 (-0.74)
Medtronic Initiates Clinical Study on Latest Heart Valve - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 5:10PM CDT
Medtronic's (MDT) structural heart business expanded in the upper teens owing to exceptional performance delivered by its transcatheter valves.
ZLTQ: 27.49 (-0.25), MDT: 68.10 (-0.64), GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21)
Stock Futures Mixed, Improving; Facebook, Orbital Sciences Dive
at Investor's Business Daily - Wed Oct 29, 8:02AM CDT
Stock futures shifted from losses to mixed trade on the approach to Wednesday's open. Dow futures improved from a narrow decline to trade 16.3 points above fair market value. S&P 500 futures narrowed their losses to a fraction. Nasdaq 100 futures...
ZLTQ: 27.49 (-0.25), ORB: 24.24 (+0.01), FB: 75.60 (+0.34)
Zeltiq beats Street 3Q forecasts
Automated Insights - Tue Oct 28, 6:52PM CDT
PLEASANTON, Calif. (AP) _ Zeltiq Aesthetics Inc. (ZLTQ) on Tuesday reported third-quarter net income of $4.8 million.
ZLTQ: 27.49 (-0.25)
ZELTIQ AESTHETICS
at Investor's Business Daily - Tue Oct 28, 5:43PM CDT
ZELTIQ AESTHETICS (ZLTQ), maker of the CoolSculpting fat-freezing tech, earned 12 cents a share vs. a year-earlier 8-cent loss and views for another 8-cent loss. Revenue surged 55% to $46 mil, topping. Zeltiq raised its full-year revenue and adjusted...
ZLTQ: 27.49 (-0.25)
Zeltiq Aesthetics Earnings: Shaping Up for Another Beat
Rick Munarriz, The Motley Fool - Motley Fool - Tue Oct 28, 4:38PM CDT
Source: Zetliq Aesthetics. Freezing away stubborn fat cells continues to pay off for Zeltiq Aesthetics . The company behind the CoolSculpting platform that's gaining traction in reshaping love handles, abdomens, and thighs posted another...
ZLTQ: 27.49 (-0.25)
ZELTIQ Announces Third Quarter 2014 Financial Results
Marketwired - Tue Oct 28, 3:06PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ)
ZLTQ: 27.49 (-0.25)
Baxter International Gets FDA Nod for Hemophilia A Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 5:45PM CDT
Baxter International Inc.'s (BAX) OBIZUR, cleared for the treatment of bleeding episodes in adults with acquired hemophilia A (AHA), will be commercially available in the U.S. in the coming months.
ZLTQ: 27.49 (-0.25), GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21), BAX: 70.61 (-0.99)
3 Things to Watch When Zeltiq Aesthetics Reports Earnings
Rick Munarriz, The Motley Fool - Motley Fool - Mon Oct 27, 12:24PM CDT
Source: Zetliq Aesthetics. Slimming down remains a challenge for a lot of people, and that's been an opportunity for Zeltiq Aesthetics . The company behind the CoolSculpting platform has been growing quickly as cosmetic surgeons, dietitians,...
ZLTQ: 27.49 (-0.25)
ResMed Posts In-Line Earnings on Revenue Beat in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:50AM CDT
Following the earnings release, ResMed's (RMD) share price rose 9.1% to close at $52.02 on Friday.
ZLTQ: 27.49 (-0.25), GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21), RMD: 51.14 (-0.43)
Strength Seen in ResMed (RMD): Stock Gains 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:46AM CDT
ResMed (RMD) was a big mover last session, with shares rising just over 9% on the day.
ICUI: 71.16 (-0.89), ZLTQ: 27.49 (-0.25), ABAX: 51.63 (-2.21), RMD: 51.14 (-0.43)
Can Fat-Freezer Zeltiq Aesthetics Heat Up Profits?
at Investor's Business Daily - Fri Oct 24, 4:50PM CDT
After some flabby years, things are shaping up for fat-busting technology developer Zeltiq Aesthetics. Zeltiq (ZLTQ) offers people a way to get rid of unwanted fat with its nonsurgical CoolSculpting procedure, which selectively reduces bulges in...
ISRG: 500.02 (-8.63), ELOS: 9.90 (+0.11), VRX: 126.11 (-2.66), ZLTQ: 27.49 (-0.25), VAR: 84.64 (-0.53), CFN: 57.28 (-0.16), STNR: 42.38 (+0.51)
Strength Seen in Cardica (CRDC): Stock Adds 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:25AM CDT
Cardica (CRDC) was a big mover last session, with shares rising over 6% on the day.
ICUI: 71.16 (-0.89), ZLTQ: 27.49 (-0.25), ABAX: 51.63 (-2.21), CRDC: 0.96 (+0.01)
Weakness Seen in Trinity Biotech (TRIB): Stock Tumbles 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 7:44AM CDT
Shares of Trinity Biotech fell nearly 8% last session and witnessed flat revision in current year estimates in the past few weeks suggest a close watch of the firm in the near future.
ZLTQ: 27.49 (-0.25), PAHC: 28.34 (+1.48), GWPH: 73.97 (-0.41), TRIB: 17.43 (-0.42)
